Evidence map›Paper›PMID 21730011›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2011

Patterns of nicotinic receptor antagonism: nicotine discrimination studies.

Emily M Jutkiewicz, Emily A Brooks, Adam D Kynaston, Kenner C Rice, James H Woods

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Assessment of Abuse-Related Discriminative Stimulus Effects of Nicotine Aerosol in Rodents.The Journal of pharmacology and experimental therapeutics · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Role of trace amine-associated receptor 1 in nicotine's behavioral and neurochemical effects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Emily M JutkiewiczDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-5632, USA.
Emily A Brooks
Adam D Kynaston
Kenner C Rice
James H Woods
University of Michigan–Ann Arbor · USNational Cancer Institute · US

Funding

POSTDOCTORAL TRAINING IN THE BIOLOGY OF DRUG ABUSET32DA007268 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 1991 to 2021
$6.7M
Medicinal Chemistry of Drugs Acting on Biogenic Amine ReceptorsZIADA000532 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2020
$4.5M
Medicinal Chemistry of Hallucinogenic DrugsZIADA000529 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI RICE, KENNER · 2009 to 2016
$864k
Intramural NIH HHSNIDA NIH HHS T32 DA007268NIDA NIH HHS T32-DA007268
6 · The paper itself

Abstract

Evaluation of the discriminative stimulus effects of drugs is a useful procedure for identification of receptor mediation of in vivo drug effects. This assay can be enhanced when the stimulus effects of different doses of agonist are evaluated. In the present study, rats were trained to discriminate small or large doses of nicotine from saline, and interactions of these effects with nicotinic receptor antagonists and partial agonists were determined. The insurmountable nicotine antagonist mecamylamine blocked both the discriminative stimulus and response rate-reducing effects of nicotine but was less effective against the large dose of nicotine. The α4β2*-selective, competitive antagonist dihydro-β-erythrodine (DHβE) antagonized the discriminative stimulus effects of both doses but was less effective against the larger training dose of nicotine. Schild analyses of DHβE suggested that different nicotinic receptor populations may be mediating the stimulus effects of large and small doses of nicotine. This suggestion was supported by observations that the discriminative stimulus effects of the partial agonist cytisine were more like those of the large dose than of the small dose of nicotine and that cytisine antagonized the effects of only the small nicotine dose. Varenicline produced nicotine-like effects in both training dose groups but reduced the discriminative stimulus effects of intermediate doses of nicotine in the group trained to the small dose of nicotine. Overall, these results suggest that small doses of nicotine produce their stimulus effects via α4β2* nicotine receptors, whereas larger doses of nicotine recruit additional nicotine receptor subtypes, as revealed by drug discrimination assays in rats.

Indexed as

AnimalsBenzazepinesBridged Bicyclo Compounds, HeterocyclicCytosineData Interpretation, StatisticalDihydro-beta-ErythroidineDiscrimination LearningDiscrimination, PsychologicalDose-Response Relationship, DrugMaleMecamylamineNicotineNicotinic AgonistsNicotinic AntagonistsPyridinesQuinoxalinesBenzazepinesBridged Bicyclo Compounds, HeterocyclicCytosineDihydro-beta-ErythroidineepibatidineMecamylamineNicotineNicotinic AgonistsNicotinic Antagonistsnicotinic receptor alpha4beta2PyridinesQuinoxalinesReceptors, NicotinicVarenicline

Identifiers

PMID21730011
PMCPMC3186295
OpenAlexW2146180900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.